Palliative medicine for the cancer and non-cancer patient

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 5, Issue 6, 2005, Pages 626-629

  Kite, Suzanne ^a   Hicks, Fiona ^b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; BISPHOSPHONIC ACID DERIVATIVE; BUPRENORPHINE; CISAPRIDE; CYTOCHROME P450; ERYTHROMYCIN; FENTANYL; HYDROMORPHONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; METHADONE; MIDAZOLAM; MORPHINE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; OPIATE ANTAGONIST; OXYCODONE; PAMIDRONIC ACID; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; ZOLEDRONIC ACID;

BONE PAIN; CANCER PAIN; CANCER PALLIATIVE THERAPY; CLINICAL PRACTICE; DELIRIUM; DEPRESSION; DRUG CONTRAINDICATION; DRUG METABOLISM; DRUG SAFETY; HEART FAILURE; HOSPICE; HUMAN; HYPERCALCEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; LIVER FAILURE; NONHUMAN; PAIN; PALLIATIVE THERAPY; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRURITUS; QT INTERVAL; QT PROLONGATION; REVIEW; SEDATION; SIDE EFFECT; VOMITING;

EID: 29244440695     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.5-6-626     Document Type: Review

References (10)

1. Department of Health. Building on the best. London: DoH, 2003.
2. Regnard C, Hunter A. Increasing prescriber awareness of drug interactions in palliative care. J Pain Symptom Manage 2005;29(3):219-21.
3. Wilcock A, Thomas J, Frisby J, Webster M et al. Potential for drug interactions involving cytochrome P450 in patients attending palliative care centres: a multicentre audit. Br J Clin Pharm 2005;60(3):326-9.
4. Olkkola KT, Aranko K, Luurila H, Hiller A et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993;53(3):298-305.
5. Twycross R, Wilcock A, Charlesworth S, Dickman A (eds). Palliative care formulary, 2nd edn. Oxford: Radcliffe, 2002.
6. Inouye SK, Bogardus ST, Charpentier PA, Leo-Summers L, Acampara D. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340(9):669-76.
7. Glassman AH, Johnson LL, Giardino EG, Walsh BT et al. The use of imipramine in depressed patients with congestive cardiac failure. JAMA 1983;250(15):1997-2001.
8. Glassman AH, O'Connor OM, Califf RM, Swedberg K. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002;288:701-9.
9. Vidal L, Shavit M, Fraser A, Paul M, Leibovici L. Systemic comparison of four sources of drug information regarding adjustment of dose for renal function. BMJ 2005;331:263.
10. Smith C, Da Silva-Gane M, Chandna S, Warwicker P, Greenwood R, Farrington K. Choosing not to dialyse: evaluation of planned non-dialytic management in a cohort of patients with end stage renal failure. Nephron Clin Pract 2003;95:c40-46.